Citation Impact
Citing Papers
Differential use of endoplasmic reticulum membrane for phagocytosis in J774 macrophages
2005 StandoutNobel
Generation of knock-in primary human T cells using Cas9 ribonucleoproteins
2015 StandoutNobel
Membrane-tethered mucin-like polypeptides sterically inhibit binding and slow fusion kinetics of influenza A virus
2020 StandoutNobel
Genome-wide CRISPR screens reveal a specific ligand for the glycan-binding immune checkpoint receptor Siglec-7
2021 StandoutNobel
Immunotype and Immunohistologic Characteristics of Tumor-Infiltrating Immune Cells Are Associated with Clinical Outcome in Metastatic Melanoma
2012
Modulation of immune cell reactivity with cis -binding Siglec agonists
2021 StandoutNobel
The PD-1/PD-L1 axis modulates the natural killer cell versus multiple myeloma effect: a therapeutic target for CT-011, a novel monoclonal anti–PD-1 antibody
2010
Brucella Evades Macrophage Killing via VirB-dependent Sustained Interactions with the Endoplasmic Reticulum
2003 Standout
MHC class I–deficient natural killer cells acquire a licensed phenotype after transfer into an MHC class I–sufficient environment
2010
A small-molecule switch for Golgi sulfotransferases
2004 StandoutNobel
Mouse models of acute and chronic hepacivirus infection
2017 StandoutScienceNobel
Education of human natural killer cells by activating killer cell immunoglobulin-like receptors
2009
Mature natural killer cells reset their responsiveness when exposed to an altered MHC environment
2010
Hierarchy of the Human Natural Killer Cell Response Is Determined by Class and Quantity of Inhibitory Receptors for Self-HLA-B and HLA-C Ligands
2007
NK Cell Responsiveness Is Tuned Commensurate with the Number of Inhibitory Receptors for Self-MHC Class I: The Rheostat Model
2009
PD-1 expression by tumour-associated macrophages inhibits phagocytosis and tumour immunity
2017 StandoutNature
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future
2004
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Targeting natural killer cells and natural killer T cells in cancer
2012
The biology of human natural killer-cell subsets
2001 Standout
Dual antibody therapy to harness the innate anti-tumor immune response to enhance antibody targeting of tumors
2015
Identification of new populations of chicken natural killer (NK) cells
2010
Mitofusin 2 tethers endoplasmic reticulum to mitochondria
2008 StandoutNature
Combination cancer immunotherapy and new immunomodulatory targets
2015
Combining immunotherapy and targeted therapies in cancer treatment
2012
The trafficking of natural killer cells
2007
Glycosulfopeptides with O-Glycans Containing Sialylated and Polyfucosylated Polylactosamine Bind with Low Affinity to P-selectin
2002
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
Host tissue determinants of tumour immunity
2019
Natural killer cell–directed therapies: moving from unexpected results to successful strategies
2008
The biology and management of non-small cell lung cancer
2018 StandoutNature
NK cells and cancer immunosurveillance
2008
Cellular ligands of activating NK receptors
2005
Microbial Flora Drives Interleukin 22 Production in Intestinal NKp46+ Cells that Provide Innate Mucosal Immune Defense
2008
Up on the tightrope: natural killer cell activation and inhibition
2008
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Liver-resident NK cells confer adaptive immunity in skin-contact inflammation
2013
NK cell education: not an on-off switch but a tunable rheostat
2009
T Cell-Dependent B Cell Activation
1993
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Multiplex messenger assay: simultaneous, quantitative measurement of expression of many genes in the context of T cell activation
1996
Specific recognition of virus‐infected cells by paired NK receptors
2004
Keeping NK cells in highly regulated antiviral warfare
2007
Interleukin-22-producing innate immune cells: new players in mucosal immunity and tissue repair?
2009
Immunoreceptor tyrosine‐based inhibition motifs: a quest in the past and future
2008
DC ablation in mice: promises, pitfalls, and challenges
2007
CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity
2003
Human nutrition, the gut microbiome and the immune system
2011 StandoutNature
Evolving synergistic combinations of targeted immunotherapies to combat cancer
2015
Renal cell carcinoma‐infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes
2003
Functions of natural killer cells
2008 Standout
Natural killer cells and malaria
2006
Mechanism of Action of Conventional and Targeted Anticancer Therapies: Reinstating Immunosurveillance
2013
Natural Killer Cell Mediated Antibody-Dependent Cellular Cytotoxicity in Tumor Immunotherapy with Therapeutic Antibodies
2013
Human natural killer cell development
2006
The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer
2015
Diet–microbiota interactions as moderators of human metabolism
2016 StandoutNature
Glycocalyx engineering reveals a Siglec-based mechanism for NK cell immunoevasion
2013 StandoutNobel
NK Cell Activating Receptors and Tumor Recognition in Humans
2005
Functional interactions between the gut microbiota and host metabolism
2012 StandoutNature
Dendritic Cells Prime Natural Killer Cells by trans-Presenting Interleukin 15
2007
'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection
2010
Taking dendritic cells into medicine
2007 StandoutNatureNobel
Activation, coactivation, and costimulation of resting human natural killer cells
2006
Functional Analysis of Human NK Cells by Flow Cytometry
2009
Impaired recruitment of the small GTPase rab7 correlates with the inhibition of phagosome maturation by Leishmania donovani promastigotes
1999
Interplay of natural killer cells and their receptors with the adaptive immune response
2004
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Prospects for the use of NK cells in immunotherapy of human cancer
2007
Costimulatory signals mediated by the ITAM motif cooperate with RANKL for bone homeostasis
2004 Nature
Golgi Localization of Carbohydrate Sulfotransferases Is a Determinant of L-selectin Ligand Biosynthesis
2003 StandoutNobel
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection
2001
Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade
2017 StandoutNobel
Current perspectives of natural killer cell education by MHC class I molecules
2010
Biogenesis of Salmonella typhimurium-containing vacuoles in epithelial cells involves interactions with the early endocytic pathway
1999
Inflammation, metaflammation and immunometabolic disorders
2017 StandoutNature
Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
2015 Standout
Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters
2009 Standout
Natural killer cell trafficking in vivo requires a dedicated sphingosine 1-phosphate receptor
2007
Small RNAs are modified with N-glycans and displayed on the surface of living cells
2021 StandoutNobel
Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy
2005
Endoplasmic Reticulum-Mediated Phagocytosis Is a Mechanism of Entry into Macrophages
2002
Domain Shuffling Has Been the Main Mechanism Forming New Hominoid Killer Cell Ig-Like Receptors
2004
Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors
2009
NK CELL RECOGNITION
2004 Standout
Signal Regulatory Protein Molecules Are Differentially Expressed by CD8− Dendritic Cells
2006
A role for interleukin-12/23 in the maturation of human natural killer and CD56+ T cells in vivo
2008
Multiplicity and plasticity of natural killer cell signaling pathways
2005
A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature
2007
Maturation of mouse NK cells is a 4-stage developmental program
2009
Regulation of Inhibitory and Activating Killer-Cell Ig-Like Receptor Expression Occurs in T Cells After Termination of TCR Rearrangements
2001
Differential natural killer cell–mediated inhibition of HIV-1 replication based on distinct KIR/HLA subtypes
2007
Regulation of the Natural Killer Cell Receptor Repertoire
2001
Interactions Between the Microbiota and the Immune System
2012 StandoutScience
KIR2DL4 (CD158d), an NK Cell-Activating Receptor with Inhibitory Potential
2002
Flt3 permits survival during infection by rendering dendritic cells competent to activate NK cells
2010 StandoutNobel
Cellular and molecular mechanisms in cancer immune escape: a comprehensive review
2013
Functional characterization of natural killer cells in type I leukocyte adhesion deficiency
2007
Impact of β2 integrin deficiency on mouse natural killer cell development and function
2011 StandoutNobel
Membrane proteomics of phagosomes suggests a connection to autophagy
2008 StandoutNobel
NK Cells and Cancer
2007
Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A
2011 StandoutNobel
Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and redefinition of inhibitory KIR specificity
2008
A Structural Basis for the Association of DAP12 with Mouse, but Not Human, NKG2D
2004
Brucella abortus Transits through the Autophagic Pathway and Replicates in the Endoplasmic Reticulum of Nonprofessional Phagocytes
1998
Interactions between Siglec-7/9 receptors and ligands influence NK cell–dependent tumor immunosurveillance
2014
Continuous engagement of a self-specific activation receptor induces NK cell tolerance
2008
Expression profiling with arrays of randomly disrupted genes in mouse embryonic stem cells leads to in vivo functional analysis
2004 StandoutNobel
Ligands for L-Selectin: Homing, Inflammation, and Beyond
2003
Expression of CD94/NKG2-A on Human T Lymphocytes Is Induced by IL-12: Implications for Adoptive Immunotherapy
2002
Structure and Function of Natural Killer Cell Receptors: Multiple Molecular Solutions to Self, Nonself Discrimination
2002
Suppression of tumor formation in lymph nodes by L-selectin–mediated natural killer cell recruitment
2005
SHP-1- and Phosphotyrosine-Independent Inhibitory Signaling by a Killer Cell Ig-Like Receptor Cytoplasmic Domain in Human NK Cells
2002
CD94/NKG2 Expression Does Not Inhibit Cytotoxic Function of Lymphocytic Choriomeningitis Virus-Specific CD8+ T Cells
2002
Genetic Control of Human NK Cell Repertoire
2002
Selective Activation of the c-Jun NH2-terminal Protein Kinase Signaling Pathway by Stimulatory KIR in the Absence of KARAP/DAP12 in CD4+ T Cells
2003
Crucial Role of DNA Methylation in Determination of Clonally Distributed Killer Cell Ig-like Receptor Expression Patterns in NK Cells
2002
Chemically tunable mucin chimeras assembled on living cells
2015 StandoutNobel
A Chemical Reporter Strategy to Probe Glycoprotein Fucosylation
2006 StandoutNobel
B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome
2007 StandoutNobel
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Live-Cell Labeling of Specific Protein Glycoforms by Proximity-Enhanced Bioorthogonal Ligation
2015 StandoutNobel
Proenkephalin+regulatory T cells expanded by ultraviolet B exposure maintain skin homeostasis with a healing function
2020 StandoutNobel
Human natural killer cells
2008
On the conservative nature of intragenic recombination
2005 StandoutNobel
Imaging the glycome
2008 StandoutNobel
Human NK Cytotoxicity against Porcine Cells Is Triggered by NKp44 and NKG2D
2005
Identification of 4Ig-B7-H3 as a neuroblastoma-associated molecule that exerts a protective role from an NK cell-mediated lysis
2004
Distinctive NK-cell receptor repertoires sustain high-level constitutive NK-cell activation in HIV-exposed uninfected individuals
2007 StandoutNobel
Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion
2005
Therapeutic cancer vaccines
2015
Killer Ig-Like Receptor Haplotype Analysis by Gene Content: Evidence for Genomic Diversity with a Minimum of Six Basic Framework Haplotypes, Each with Multiple Subsets
2002
Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity
2017 StandoutNobel
Innate or Adaptive Immunity? The Example of Natural Killer Cells
2011 StandoutScience
Recombinant immunotoxin for cancer treatment with low immunogenicity by identification and silencing of human T-cell epitopes
2014 StandoutNobel
Works of Pascale André being referenced
Profound Coordinated Alterations of Intratumoral NK Cell Phenotype and Function in Lung Carcinoma
2011
Anti-KIR antibody enhancement of anti-lymphoma activity of natural killer cells as monotherapy and in combination with anti-CD20 antibodies
2013
Biochemical and functional association between CD8 and H-2 at the surface of a T cell clone
1991
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
2018
Association of signal-regulatory proteins β with KARAP/DAP-12
2000
Comparative analysis of human NK cell activation induced by NKG2D and natural cytotoxicity receptors
2004
The PEN5 Epitope Identifies an Oligodendrocyte Precursor Cell Population and Pilocytic Astrocytomas
1999
Clinical Analysis of Human Natural Killer Cells
2008
Differential regulation of killer cell Ig-like receptors and CD94 lectin-like dimers on NK and T lymphocytes from HIV-1-infected individuals
1999
Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity
2011
Flow cytometric sorting and biochemical characterization of the late endosomal rab7‐containing compartment
1997
Human NK Cell Education by Inhibitory Receptors for MHC Class I
2006
New nomenclature for MHC receptors
2001
Association of signal-regulatory proteins β with KARAP/DAP-12
2000
Genetic and antibody-mediated reprogramming of natural killer cell missing-self recognition in vivo
2009
Modification of P-selectin glycoprotein ligand-1 with a natural killer cell-restricted sulfated lactosamine creates an alternate ligand for L-selectin
2000
A phase 1 trial of the anti-inhibitory KIR mAb IPH2101 for AML in complete remission
2012
Distinct structural compartmentalization of the signal transducing functions of major histocompatibility complex class II (Ia) molecules.
1994
IPH2101, a novel anti-inhibitory KIR antibody, and lenalidomide combine to enhance the natural killer cell versus multiple myeloma effect
2011
Identification, activation, and selectivein vivoablation of mouse NK cells via NKp46
2007
Preclinical characterization of 1-7F9, a novel human anti–KIR receptor therapeutic antibody that augments natural killer–mediated killing of tumor cells
2009